del Vecchio, M T <br/><br/>
Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes.  [electronic resource] 

 -  The Prostate  Sep 2000 
 - 51-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0270-4137 
<br/><br/><label>Standard No.: </label>10.1002/1097-0045(20000915)45:1<51::aid-pros6>3.0.co;2-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Aged<br/>Androgen Antagonists--administration & dosage<br/>Androgens--physiology<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biopsy, Needle<br/>Cell Differentiation--drug effects<br/>Flutamide--administration & dosage<br/>Gonadotropin-Releasing Hormone--agonists<br/>Humans<br/>Immunohistochemistry<br/>Macrophage Migration-Inhibitory Factors--biosynthesis<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Prognosis<br/>Prostate--metabolism<br/>Prostatic Intraepithelial Neoplasia--drug therapy<br/>Prostatic Neoplasms--drug therapy